Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
Biochemistry
|
April 17, 2002
Receptor type I and type II binding regions and the peptidyl-prolyl isomerase site of cyclophilin B are required for enhancement of T-lymphocyte adhesion to fibronectin
Mathieu Carpentier, Fabrice Allain, Marie-Christine Slomianny, et al.
Cancers
|
January 8, 2023
Comparative Proteomic and Transcriptomic Analysis of the Impact of Androgen Stimulation and Darolutamide Inhibition
Ekaterina Nevedomskaya, Tatsuo Sugawara, Simon J Baumgart, et al.
International Journal of Cancer
|
October 2, 2012
HDAC11 is a novel drug target in carcinomas
Hedwig E Deubzer, Marie C Schier, Ina Oehme, et al.
International Journal of Cancer
|
March 5, 2019
Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models
Tatsuo Sugawara, Simon J Baumgart, Ekaterina Nevedomskaya, et al.
Journal of Biomolecular Screening
|
October 1, 2014
Cell-based protein stabilization assays for the detection of interactions between small-molecule inhibitors and BRD4
Jessica Schulze, Dieter Moosmayer, Joerg Weiske, et al.
Molecular Human Reproduction
|
March 27, 2004
Cyr61, a deregulated gene in endometriosis
Yvonne Absenger, Holger Hess-Stumpp, Bertolt Kreft, et al.
BMC Evolutionary Biology
|
December 20, 2008
The fate of the duplicated androgen receptor in fishes: a late neofunctionalization event?
Véronique Douard, Frédéric Brunet, Bastien Boussau, et al.
BMC Genomics
|
February 8, 2008
High-throughput mammalian two-hybrid screening for protein-protein interactions using transfected cell arrays
Andrea Fiebitz, Lajos Nyarsik, Bernard Haendler, et al.
Cancer Medicine
|
December 11, 2014
Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis
Julia C Meier, Bernard Haendler, Henrik Seidel, et al.
European Urology
|
May 3, 2008
Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma
Hellmuth-A Meyer, Angelika Tölle, Monika Jung, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
Biochemistry
|
April 17, 2002
Receptor type I and type II binding regions and the peptidyl-prolyl isomerase site of cyclophilin B are required for enhancement of T-lymphocyte adhesion to fibronectin
Mathieu Carpentier, Fabrice Allain, Marie-Christine Slomianny, et al.
Cancers
|
January 8, 2023
Comparative Proteomic and Transcriptomic Analysis of the Impact of Androgen Stimulation and Darolutamide Inhibition
Ekaterina Nevedomskaya, Tatsuo Sugawara, Simon J Baumgart, et al.
International Journal of Cancer
|
October 2, 2012
HDAC11 is a novel drug target in carcinomas
Hedwig E Deubzer, Marie C Schier, Ina Oehme, et al.
International Journal of Cancer
|
March 5, 2019
Darolutamide is a potent androgen receptor antagonist with strong efficacy in prostate cancer models
Tatsuo Sugawara, Simon J Baumgart, Ekaterina Nevedomskaya, et al.
Journal of Biomolecular Screening
|
October 1, 2014
Cell-based protein stabilization assays for the detection of interactions between small-molecule inhibitors and BRD4
Jessica Schulze, Dieter Moosmayer, Joerg Weiske, et al.
Molecular Human Reproduction
|
March 27, 2004
Cyr61, a deregulated gene in endometriosis
Yvonne Absenger, Holger Hess-Stumpp, Bertolt Kreft, et al.
BMC Evolutionary Biology
|
December 20, 2008
The fate of the duplicated androgen receptor in fishes: a late neofunctionalization event?
Véronique Douard, Frédéric Brunet, Bastien Boussau, et al.
BMC Genomics
|
February 8, 2008
High-throughput mammalian two-hybrid screening for protein-protein interactions using transfected cell arrays
Andrea Fiebitz, Lajos Nyarsik, Bernard Haendler, et al.
Cancer Medicine
|
December 11, 2014
Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis
Julia C Meier, Bernard Haendler, Henrik Seidel, et al.
European Urology
|
May 3, 2008
Identification of stanniocalcin 2 as prognostic marker in renal cell carcinoma
Hellmuth-A Meyer, Angelika Tölle, Monika Jung, et al.
Page
of 6